{"prompt": "['2017N330177_04', 'CONFIDENTIAL', '205678', 'Deep venous thrombosis/pulmonary embolism', 'Revascularization', 'Recording AE and SAE', 'AE and SAE Recording', 'When an AE/SAE occurs, it is the responsibility of the investigator to review all', 'documentation (e.g., hospital progress notes, laboratory, and diagnostics reports)', 'related to the event.', 'The investigator will then record all relevant AE/SAE information in the CRF.', \"It is not acceptable for the investigator to send photocopies of the participant's\", 'medical records to GSK in lieu of completion of the GSK/AE/SAE CRF page.', 'There may be instances when copies of medical records for certain cases are', 'requested by GSK. In this case, all participant identifiers, with the exception of the', 'participant number, will be redacted on the copies of the medical records before', 'submission to GSK.', 'The investigator will attempt to establish a diagnosis of the event based on signs,', 'symptoms, and/or other clinical information. Whenever possible, the diagnosis (not', 'the individual signs/symptoms) will be documented as the AE/SAE.', 'Assessment of Intensity', 'The investigator will make an assessment of intensity for each AE and SAE reported', 'during the study and assign it to 1 of the following categories:', 'Grade 1: Mild; asymptomatic or mild symptoms; clinical or diagnostic observations', 'only; intervention not indicated.', 'Grade 2: Moderate; minimal, local or noninvasive intervention indicated; limiting age-', 'appropriate instrumental ADL*', 'Grade 3: Severe or medically significant but not immediately life-threatening;', 'hospitalization or prolongation of hospitalization indicated; disabling; limiting self-care', 'ADL **', 'Grade 4: Life-threatening consequences; urgent intervention indicated.', 'Grade 5: Death related to AE.', '*Instrumental ADL refer to preparing meals, shopping for groceries or clothes, using the telephone, managing money,', 'etc.', '**Self-care ADL refer to bathing, dressing and undressing, feeding self, using the toilet, taking medications, and not', 'bedridden.', '119']['2017N330177_04', 'CONFIDENTIAL', '205678', 'Assessment of Causality', 'The investigator is obligated to assess the relationship between study treatment and', 'each occurrence of each AE/SAE.', 'A \"reasonable possibility\" of a relationship conveys that there are facts, evidence,', 'and/or arguments to suggest a causal relationship, rather than a relationship cannot', 'be ruled out.', 'The investigator will use clinical judgment to determine the relationship.', 'Alternative causes, such as underlying disease(s), concomitant therapy, and other', 'risk factors, as well as the temporal relationship of the event to study treatment', 'administration will be considered and investigated.', \"The investigator will also consult the Investigator's Brochure (IB) and/or Product\", 'Information, for marketed products, in his/her assessment.', 'For each AE/SAE, the investigator must document in the medical notes that he/she', 'has reviewed the AE/SAE and has provided an assessment of causality.', 'There may be situations in which an SAE has occurred and the investigator has', 'minimal information to include in the initial report to GSK. However, it is very', 'important that the investigator always make an assessment of causality for', 'every event before the initial transmission of the SAE data to GSK.', 'The investigator may change his/her opinion of causality in light of follow-up', 'information and send an SAE follow-up report with the updated causality', 'assessment.', 'The causality assessment is one of the criteria used when determining regulatory', 'reporting requirements.', 'Follow-up of AE and SAE', 'The investigator is obligated to perform or arrange for the conduct of supplemental', 'measurements and/or evaluations as medically indicated or as requested by GSK to', 'elucidate the nature and/or causality of the AE or SAE as fully as possible. This may', 'include additional laboratory tests or investigations, histopathological examinations,', 'or consultation with other health care professionals.', 'New or updated information will be recorded in the originally completed CRF.', 'The investigator will submit any updated SAE data to GSK within 24 hours of', 'receipt of the information.', '120']\n\n###\n\n", "completion": "END"}